Status: Recruiting
Mitral Annular Repair With the CathHELIX™ Transcatheter System in Subjects With FMR
Patients with functional mitral regurgitation classified as moderate to severe (3+) or severe (4+) that are symptomatic (NYHA Class II-IV) will be evaluated for treatment using the CathHELIX Transcatheter Mitral Annuloplasty System.
Participants needed: 5
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: HVR Cardio OyUpdated: Sep 23, 2025Locations: 2
Eligibility criteria
Moderate to severe (3+) or severe (4+) functional mitral regurgitation [+2]
Oxygen dependent for COPD [+5]